Celldex Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $222k | 6.5k | 33.99 |
| 2024-06-30 | $229k | 6.2k | 37.01 |
| 2024-03-31 | $260k | 6.2k | 41.97 |
| 2023-12-31 | $183k | 4.6k | 39.66 |
| 2023-09-30 | $127k | 4.6k | 27.52 |
| 2023-06-30 | $130k | 3.8k | 33.93 |
| 2023-03-31 | $127k | 3.5k | 35.98 |
| 2022-12-31 | $164k | 3.5k | 46.59 |
| 2022-09-30 | $99k | 3.5k | 28.09 |
| 2022-06-30 | $95k | 3.5k | 26.95 |
| 2022-03-31 | $120k | 3.5k | 34.04 |
| 2021-12-31 | $136k | 3.5k | 38.58 |
| 2021-09-30 | $190k | 3.5k | 53.90 |
| 2021-06-30 | $103k | 3.1k | 33.51 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors